GlassScriptPhysician profile
Linden R Pearson
NPI 1154482438
$1,925.72
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $551.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $385.89 | 2019-2020 | |
| Allergan, INC. | $359.76 | 2019-2020 | |
| Amgen INC. | $158.36 | 2019-2020 | |
| Pfizer INC. | $152.98 | 2019-2020 | |
| Glaxosmithkline, LLC. | $126.51 | 2019 | |
| Novo Nordisk INC | $118.27 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.58 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $100.26 | 2019-2020 | |
| Lilly USA, LLC | $79.91 | 2019-2020 | |
| Amarin Pharma, INC. | $61.34 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $56.60 | 2019 | |
| Merck Sharp & Dohme LLC | $43.48 | 2019 | |
| Hikma Pharmaceuticals USA | $25.97 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $23.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.72 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Promius Pharma LLC | $16.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.88 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.79 | 2019 | |
| Antares Pharma, INC. | $12.08 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.94 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.92 | 2019 | |
| Assertio Therapeutics, INC. | $11.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linden Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.